ZA853690B - Immunoregulation - Google Patents

Immunoregulation

Info

Publication number
ZA853690B
ZA853690B ZA853690A ZA853690A ZA853690B ZA 853690 B ZA853690 B ZA 853690B ZA 853690 A ZA853690 A ZA 853690A ZA 853690 A ZA853690 A ZA 853690A ZA 853690 B ZA853690 B ZA 853690B
Authority
ZA
South Africa
Prior art keywords
immunoregulation
epipolythiodioxopiperazines
recipient
implantation
compound
Prior art date
Application number
ZA853690A
Other languages
English (en)
Inventor
Ronald David Eichner
Arno Mullbacher
Original Assignee
Ronald David Eichner
Muelbacher Arno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ronald David Eichner, Muelbacher Arno filed Critical Ronald David Eichner
Publication of ZA853690B publication Critical patent/ZA853690B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/185Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/66Aspergillus
    • C12R2001/68Aspergillus fumigatus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
ZA853690A 1984-05-18 1985-05-15 Immunoregulation ZA853690B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPG505384 1984-05-18

Publications (1)

Publication Number Publication Date
ZA853690B true ZA853690B (en) 1985-12-24

Family

ID=3770617

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA853690A ZA853690B (en) 1984-05-18 1985-05-15 Immunoregulation

Country Status (8)

Country Link
US (2) US4727018A (xx)
EP (1) EP0163475B1 (xx)
JP (1) JPH07119227B2 (xx)
AT (1) ATE71298T1 (xx)
CA (1) CA1278542C (xx)
DE (1) DE3585102D1 (xx)
NZ (1) NZ212051A (xx)
ZA (1) ZA853690B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935000A (en) * 1986-04-03 1990-06-19 East Carolina University Extracellular matrix induction method to produce pancreatic islet tissue
US6514238B1 (en) * 1989-08-14 2003-02-04 Photogenesis, Inc. Method for preparation and transplantation of volute grafts and surgical instrument therefor
US5817075A (en) * 1989-08-14 1998-10-06 Photogenesis, Inc. Method for preparation and transplantation of planar implants and surgical instrument therefor
SG49267A1 (en) * 1989-08-14 1998-05-18 Photogenesis Inc Surgical instrument and cell isolation and transplantation
JPH06503344A (ja) * 1990-12-06 1994-04-14 ティーセル サイエンシズ,インコーポレーテッド 可溶性の補体受容体と、補体を抑制しかつ/または免疫活性を抑制する化合物との相乗組成物
US5328821A (en) * 1991-12-12 1994-07-12 Robyn Fisher Cold and cryo-preservation methods for human tissue slices
US6045791A (en) * 1992-03-06 2000-04-04 Photogenesis, Inc. Retinal pigment epithelium transplantation
US5874082A (en) * 1992-07-09 1999-02-23 Chiron Corporation Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation
US5747034A (en) * 1992-07-09 1998-05-05 Chiron Corporation Methods and materials for the induction of T cell anergy
US5397703A (en) * 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
WO1994028897A2 (en) * 1993-06-07 1994-12-22 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
US5868728A (en) * 1995-02-28 1999-02-09 Photogenesis, Inc. Medical linear actuator for surgical delivery, manipulation, and extraction
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
JP4261049B2 (ja) 1997-10-08 2009-04-30 アイソテクニカ インコーポレイテッド 重水素化シクロスポリンアナログおよび免疫調節剤としてのそれらの使用
EP1311269B1 (en) 2000-08-04 2012-02-29 DMI Biosciences, Inc. Method of using diketopiperazines and composition containing them
US7288252B2 (en) * 2000-10-02 2007-10-30 Novartis Vaccines And Diagnostics, Inc. Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
PL210795B1 (pl) 2001-10-19 2012-03-30 Isotechnika Inc Sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (E), sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (Z), sposób stereoselektywnej syntezy izomeru (E) ISATX247, sposób stereoselektywnej syntezy izomeru (Z) ISATX247 i sposób wytwarzania mieszaniny izomerów ISATX247
JP2005517468A (ja) * 2002-02-14 2005-06-16 フォトジェネシス インコーポレイテッド 網膜下移植装置および同装置と共に使用されるカニューレ
ES2572975T3 (es) 2003-05-15 2016-06-03 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
US20050069958A1 (en) * 2003-09-26 2005-03-31 Mills Rhonda A. Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
US20060024744A1 (en) * 2004-07-28 2006-02-02 Mills Rhonda A Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte
ITMI20042477A1 (it) * 2004-12-23 2005-03-23 Cell Therapeutics Europe Srl Uso di antibiotici a strutura dichetoditiopiperazinica per la preparazione di composizioni farmaceutiche antiangiogeniche
AT502055B1 (de) 2005-06-21 2007-11-15 Univ Wien Med Anti tumor medikament
KR100936277B1 (ko) * 2007-11-20 2010-01-13 한국과학기술연구원 스핑고모나스 속 박테리아 균주와 아스페질러스 속 곰팡이균주의 혼합배양방법, 이로부터 유래한 신규항암-항생물질인 글리오니트린, 및 상기 글리오니트린 또는이의 약학적으로 허용가능한 염을 유효성분으로 하는약학적 조성물
US8217047B2 (en) 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
JP2013537195A (ja) 2010-09-07 2013-09-30 ディエムアイ アクイジション コーポレイション 疾患の治療
MX2014003856A (es) 2011-10-10 2015-01-16 Ampio Pharmaceuticals Inc Dispositivos medicos implantables con tolerancia inmune incrementada y metodos para hacerlos e implantarlos.
CN103841987B (zh) 2011-10-10 2015-06-17 安皮奥制药股份有限公司 退行性关节病的治疗
SG10201605205VA (en) 2011-10-28 2016-08-30 Ampio Pharmaceuticals Inc Treatment of rhinitis
AU2013334707B2 (en) * 2012-10-22 2018-02-22 City Of Hope ETP derivatives
EP2968315B1 (en) 2013-03-15 2020-06-03 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
EP3183240A4 (en) 2014-08-18 2018-06-27 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562253A (en) * 1968-07-15 1971-02-09 American Cyanamid Co 1,4 - dialkyl - 2,5 - piperazinedione - 3,6 - dithioacetates,-dithiols,-disulfides and -tetrasulfides
JPS50116486A (xx) * 1974-03-02 1975-09-11
CA1106303A (en) * 1975-11-04 1981-08-04 Maz Kuhn Cyclosporin c from tolypocladium or cylindrocarbon
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
US4215199A (en) * 1978-06-05 1980-07-29 Sandoz Ltd. Antibiotic production
EP0034567B1 (en) * 1980-02-14 1984-11-07 Sandoz Ag A method for the total synthesis of cyclosporins and novel cyclosporins

Also Published As

Publication number Publication date
JPH07119227B2 (ja) 1995-12-20
CA1278542C (en) 1991-01-02
ATE71298T1 (de) 1992-01-15
US4886796A (en) 1989-12-12
EP0163475A2 (en) 1985-12-04
JPS6156186A (ja) 1986-03-20
EP0163475A3 (en) 1987-10-14
NZ212051A (en) 1988-10-28
US4727018A (en) 1988-02-23
DE3585102D1 (en) 1992-02-20
EP0163475B1 (en) 1992-01-08

Similar Documents

Publication Publication Date Title
EP0163475A3 (en) Immunoregulation
AU5017685A (en) Implantable bioprosthetic tendons and ligaments
IT209301Z2 (it) Protesi uditiva.
DE3578806D1 (de) Hueftimplantat.
FR2562407B3 (fr) Corps porteur droit eclaire pour recipients de plantes, fleurs et autres
EP0139468A3 (en) Hair treatment composition
IL74680A (en) Immunosuppressant factor derived from human glioblastoma cells
EP0049341A3 (en) Process for conditioning and implanting alloplastic implants and organ grafts, as well as for pretreating the recipient
FR2393565A1 (fr) Procede et dispositif de fixation amovible de protheses, notamment de protheses dentaires
MY106158A (en) Inhibition of allograft and concordant xenograft rejection
NO850990L (no) Intraokulart implantat.
ES2005159A6 (es) Procedimiento para diagnostico y seguimiento de hepatopatias mediante determinacion de factor de crecimiento hepatico en plasma yno suero sanguineo.
SU1220180A1 (ru) Установка для массообмена
SU1251528A1 (ru) Пленка - подложка для культивирования животных клеток
EP0264748A3 (en) Cell culture medium made from cohn supernatant fraction v
SU1269296A1 (ru) Гербицидный состав
SU1264575A1 (ru) Способ иммобилизации клеток
ES457071A1 (es) Un procedimiento para preparar composiciones de s-triazina- triona clorada.
SU1269688A1 (ru) Источник ионов
SU1241748A1 (ru) Способ разработки нефтяного месторождения
PL247356A2 (en) Small mechanical-biological sewage treatment plant
SU1235275A1 (ru) Газоотвод судовой газотурбинной установки
SU1083739A1 (ru) Стокс-калибратор
SU1263148A1 (ru) Интегральная микросхема
PL247826A1 (en) Distillery wastes treatment plant